Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson’s disease, and correlates with levodopa equivalent daily dose
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1761, 147411
Abstract
No abstract availableKeywords
Funding Information
- Neurology Andalusian Society
- Carlos III Health Institute
- European Research Council
- Government of Andalusia Ministry of Economy Science Innovation and Employment
- Government of Spain Ministry of Health Consumer Affairs and Social Welfare
This publication has 54 references indexed in Scilit:
- Effects of Habitual Coffee Consumption on Cardiometabolic Disease, Cardiovascular Health, and All-Cause MortalityJACC, 2013
- Physical and catalytic properties of a peroxidase derived from cytochrome cBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- In parkinsonian substantia nigra, α-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activityJournal of Neural Transmission, 2007
- Ablation of the Inflammatory Enzyme Myeloperoxidase Mitigates Features of Parkinson's Disease in MiceJournal of Neuroscience, 2005
- Infectious agents and age-related neurodegenerative disordersAgeing Research Reviews, 2004
- AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patientsKidney International, 2003
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's diseaseAnnals of Neurology, 2002
- ParkinsonismNeurology, 1967